Back to Feed
ClinicalTrials.gov|Clinical Trial
TriPRIL CAR T Cells in Multiple Myeloma
Marcela V. Maus, M.D.,Ph.D.
Abstract
This research study involves the study of TriPRIL CAR T Cells for treating people with relapsed or refractory multiple myeloma and to understand the side effects when treated with TriPRIL CAR T Cells. This research study involves the study drugs:. * TriPRIL CAR T Cells * Fludarabine and Cyclophosphamide: Standardly used chemotherapy drugs as part of lymphodepleting process Phase: PHASE1 Status: RECRUITING Conditions: Multiple Myeloma; Multiple Myeloma in Relapse; Refractory Multiple Myeloma Interventions: TriPRIL CAR T Cells; Cyclophosphamide; Fludarabine
Keywords
Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple Myeloma